Cargando…

Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer

The immune microenvironment is a culmination of the collaborative effort of immune cells and is important in cancer development. The underlying mechanisms of the tumor immune microenvironment in regulating prostate cancer (PRAD) are unclear. In the current study, 144 natural killer cell-related gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ruisong, Xiao, Yaqian, Pan, Meisen, Chen, Zhongyuan, Yang, Pinhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325591/ https://www.ncbi.nlm.nih.gov/pubmed/35909899 http://dx.doi.org/10.1155/2022/6768139

Ejemplares similares

Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer
por: Wang, Zitao, et al.
Publicado: (2023)

Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple Myeloma
por: Zhao, Jing, et al.
Publicado: (2022)

ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma
por: Yao, Wenchao, et al.
Publicado: (2022)

Single-cell RNA-Seq unveils tumor microenvironment
por: Lee, Hae-Ock, et al.
Publicado: (2017)

Unveiling mitophagy-mediated molecular heterogeneity and development of a risk signature model for colorectal cancer by integrated scRNA-seq and bulk RNA-seq analysis
por: Gao, Han, et al.
Publicado: (2023)

Integration of scRNA-Seq and Bulk RNA-Seq Reveals Molecular Characterization of the Immune Microenvironment in Acute Pancreatitis
por: Fang, Zhen, et al.
Publicado: (2022)

Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma
por: Wan, Sicheng, et al.
Publicado: (2022)

Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma
por: Zhao, Yang, et al.
Publicado: (2022)

Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer
por: Pei, Shengbin, et al.
Publicado: (2023)

Gene Mapping via Bulked Segregant RNA-Seq (BSR-Seq)
por: Liu, Sanzhen, et al.
Publicado: (2012)

SCRABBLE: single-cell RNA-seq imputation constrained by bulk RNA-seq data
por: Peng, Tao, et al.
Publicado: (2019)

Effective methods for bulk RNA-seq deconvolution using scnRNA-seq transcriptomes
por: Cobos, Francisco Avila, et al.
Publicado: (2023)

Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data
por: Cao, Lichao, et al.
Publicado: (2023)

Prognostic value of PNN in prostate cancer and its correlation with therapeutic significance
por: Wang, Ruisong, et al.
Publicado: (2022)

Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq
por: He, Puxing, et al.
Publicado: (2023)

Pan-cancer Analysis Reveals SRC May Link Lipid Metabolism and Macrophages
por: Chen, Zhongyuan, et al.
Publicado: (2023)

T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing
por: Chi, Hao, et al.
Publicado: (2023)

Integrated Analysis of Single-Cell RNA-Seq and Bulk RNA-Seq Combined with Multiple Machine Learning Identified a Novel Immune Signature in Diabetic Nephropathy
por: Peng, Yue-Ling, et al.
Publicado: (2023)

Integration of scRNA-Seq and bulk RNA-Seq uncover perturbed immune cell types and pathways of Kawasaki disease
por: Cao, Naixin, et al.
Publicado: (2023)

Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC
por: Wu, Xiaoqing, et al.
Publicado: (2023)

An Efficient and Flexible Method for Deconvoluting Bulk RNA-Seq Data with Single-Cell RNA-Seq Data
por: Sun, Xifang, et al.
Publicado: (2019)

Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia
por: Li, Zhongzheng, et al.
Publicado: (2023)

Prime-seq, efficient and powerful bulk RNA sequencing
por: Janjic, Aleksandar, et al.
Publicado: (2022)

Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma
por: Liu, Yunxun, et al.
Publicado: (2023)

Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model
por: Tan, Zhiyong, et al.
Publicado: (2023)

Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq
por: Zhang, Dongni, et al.
Publicado: (2022)

Identification of Pathogen Signatures in Prostate Cancer Using RNA-seq
por: Chen, Yunqin, et al.
Publicado: (2015)

Single‐cell RNA‐seq and bulk RNA‐seq explore the prognostic value of exhausted T cells in hepatocellular carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2023)

Prognosis and therapeutic benefits prediction based on NK cell marker genes through single-cell RNA-seq with integrated bulk RNA-seq analysis for hepatocellular carcinoma
por: Yang, Yao, et al.
Publicado: (2023)

A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation
por: Xiang, Xuebao, et al.
Publicado: (2022)

Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights
por: Ma, Yixuan, et al.
Publicado: (2023)

Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq
por: Liu, Xiaorui, et al.
Publicado: (2022)

Integrating Single-Cell RNA-Seq and Bulk RNA-Seq Data to Explore the Key Role of Fatty Acid Metabolism in Breast Cancer
por: Chen, Yongxing, et al.
Publicado: (2023)

Deep learning using bulk RNA-seq data expands cell landscape identification in tumor microenvironment
por: Wang, Xin, et al.
Publicado: (2022)

Delving into the Heterogeneity of Different Breast Cancer Subtypes and the Prognostic Models Utilizing scRNA-Seq and Bulk RNA-Seq
por: Xu, Jieyun, et al.
Publicado: (2022)

Integrated analysis of single-cell and bulk RNA-seq establishes a novel signature for prediction in gastric cancer
por: Wen, Fei, et al.
Publicado: (2023)

Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data
por: Yu, Lianghe, et al.
Publicado: (2022)

Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model
por: Liang, Leilei, et al.
Publicado: (2021)

Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients
por: Chen, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gcmvmm36ulurhg4rhbmqgile55